Ekkehard Schütz

Direttore Tecnico/Scientifico/R&S presso ONCOCYTE CORPORATION

Patrimonio netto: - $ in data 31/05/2024

Health Technology

Consumer Services

Posizioni attive di Ekkehard Schütz

Società	Posizione	Inizio	Fine
ONCOCYTE CORPORATION	Direttore Tecnico/Scientifico/R&S	01/04/2021	-
Chronix Biomedical, Inc. Chronix Biomedical, Inc. Medical SpecialtiesHealth Technology Chronix Biomedical, Inc. manufactures diagnostic substances chemicals. It develops DNA-based blood tests primarily for monitoring minimal residual disease in cancer patients. The firm also develops a technology that measures personalized biomarkers in cancers of the colorectum, prostate, lung, ovarian, pancreas, blood and central nervous system. The company was founded by Wiiliam A. Boeger and Howard B. Urnovitz in 1997 and is headquartered in San Jose, CA.	Amministratore Delegato	-	-
	Direttore Tecnico/Scientifico/R&S	-	-
Chronix Biomedical GmbH	Corporate Officer/Principal	01/04/2011	-

University of Gottingen

Doctorate Degree

Distribuzione geografica

Stati Uniti	3
Germania	3

Posizioni

Settori

Health Technology	3
Consumer Services	2

Posizioni ricoperte

Attive

Inattive

Società quotate in Borsa

Aziende private

Società quotate in Borsa	1
ONCOCYTE CORPORATION	Health Technology

Aziende private	2
Chronix Biomedical, Inc. Chronix Biomedical, Inc. Medical SpecialtiesHealth Technology Chronix Biomedical, Inc. manufactures diagnostic substances chemicals. It develops DNA-based blood tests primarily for monitoring minimal residual disease in cancer patients. The firm also develops a technology that measures personalized biomarkers in cancers of the colorectum, prostate, lung, ovarian, pancreas, blood and central nervous system. The company was founded by Wiiliam A. Boeger and Howard B. Urnovitz in 1997 and is headquartered in San Jose, CA.	Health Technology
Chronix Biomedical GmbH

Aziende private

Health Technology

Chronix Biomedical GmbH